Related Experiment Video
Updated: May 25, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Genomic approach towards personalized anticancer drug therapy
Yutaka Midorikawa1, Shingo Tsuji, Tadatoshi Takayama
1Genome Science Division, Research Center for Advanced Science & Technology, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo 153-8904, Japan.
Abstract:
Stratification of patients for multidrug response is a promising strategy for cancer treatment. Genome-based prediction models have great potential for this purpose because the extent of drug sensitivity may be attributed to the heterogeneity of the underlying genetic characteristics of cancer. However, microarray data is difficult to analyze and is not reproducible. Several machine-learning algorithms have therefore been developed in a repeatable manner. Random forests algorithm, which uses an ensemble approach based on classification and regression trees, appears to be superior for predicting multidrug sensitivity. This is because ensemble methods are more effective when there are much more predictors than samples. Here, we review recent advances in the development of classification algorithms using microarray technology for prediction of anticancer sensitivity, discuss the availability of ensemble methods for prediction models, and present data regarding the identification of potential responders to FOLFOX therapy using random forests algorithm.
Insights
Predicting cancer multidrug response using genome-based models is promising. Random forests algorithm shows superiority in identifying patients who will respond to chemotherapy, like FOLFOX, improving cancer treatment strategies.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Research
Background:
- Patient stratification for multidrug response is key in cancer therapy.
- Genome-based prediction models offer potential but face challenges with microarray data analysis.
- Machine learning algorithms provide reproducible methods for analyzing complex genomic data.
Purpose of the Study:
- To review advances in classification algorithms for predicting anticancer drug sensitivity using microarray data.
- To discuss the utility of ensemble methods in predictive modeling.
- To present findings on identifying potential responders to FOLFOX therapy using the random forests algorithm.
Main Methods:
- Review of machine learning algorithms for microarray data analysis.
- Focus on ensemble methods, specifically the random forests algorithm.
- Application of random forests to predict response to FOLFOX therapy.
Main Results:
- Random forests algorithm demonstrates superiority in predicting multidrug sensitivity.
- Ensemble methods are effective when the number of predictors exceeds the number of samples.
- Identification of potential responders to FOLFOX therapy based on genomic data.
Conclusions:
- Random forests algorithm is a robust tool for predicting anticancer drug response.
- Genomic data combined with machine learning can personalize cancer treatment.
- This approach aids in identifying patients likely to benefit from specific therapies like FOLFOX.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Pharmacogenetics and Pharmacogenomics: Overview

